Department of Biomedical Engineering, University Medical Center Groningen, and University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.
J Biomed Mater Res A. 2012 Dec;100(12):3220-6. doi: 10.1002/jbm.a.34258. Epub 2012 Jun 26.
Cementless prostheses are increasingly popular in total hip arthroplasties. Therewith, common prophylactic measures to reduce the risk of postoperative infection like the use of antibiotic-loaded bone cements, will no longer be available. Alternative prophylactic measures may include the use of antibiotic-releasing coatings. Previously, we developed a gentamicin-releasing coating for cementless titanium hip prostheses and derived an appropriate dosing of this coating by adjusting the amount of gentamicin in the coating to match the antibacterial efficacy of clinically employed gentamicin-loaded bone cement. In this manuscript, we investigated two important issues regarding the prophylactic use of this 1 mg cm(-2) bioactive gentamicin-releasing coating in cementless total hip arthroplasty: (1) its ability to prevent bacterial growth in a geometrically relevant set-up and (2) its antibacterial spectrum. A geometrically relevant set-up was developed in which miniature titanium stems were surrounded by agar, contaminated with bioluminescent Staphylococcus aureus. Novel, bio-optical imaging was performed allowing noninvasive, longitudinal monitoring of staphylococcal growth around miniature stems with and without the gentamicin-releasing coating. Furthermore, the antibacterial efficacy of the gentamicin-releasing coating was determined against a wide variety of clinical isolates, including bioluminescent Staphylococcus aureus strains, using traditional zone of inhibition measurements. The gentamicin-releasing coating demonstrated a wide-spectrum of antibacterial efficacy and successfully prevented growth of bioluminescent staphylococci around a miniature stem mounted in bacterially contaminated agar for at least 60 h. This implies that the gentamicin-releasing coating has potential to contribute to the improvement of infection prophylaxis in cementless total hip arthroplasty.
无水泥假体在全髋关节置换术中越来越受欢迎。因此,减少术后感染风险的常见预防措施,如使用载抗生素骨水泥,将不再可用。替代预防措施可能包括使用抗生素释放涂层。此前,我们为无水泥钛髋假体开发了一种庆大霉素释放涂层,并通过调整涂层中的庆大霉素含量来匹配临床使用的载抗生素骨水泥的抗菌功效,从而得出这种涂层的适当剂量。在本文中,我们研究了在无水泥全髋关节置换术中预防性使用这种 1mg cm(-2) 生物活性庆大霉素释放涂层的两个重要问题:(1)它在几何相关设置中预防细菌生长的能力;(2)它的抗菌谱。开发了一种几何相关的设置,其中微型钛柱被琼脂包围,琼脂被生物发光金黄色葡萄球菌污染。新型生物光学成像用于非侵入性、纵向监测微型柱周围金黄色葡萄球菌的生长情况,包括有无庆大霉素释放涂层。此外,使用传统的抑菌圈测量法,确定了庆大霉素释放涂层对多种临床分离株(包括生物发光金黄色葡萄球菌株)的抗菌功效。庆大霉素释放涂层表现出广谱的抗菌功效,并成功地防止了载有生物发光葡萄球菌的微型柱在细菌污染的琼脂中生长至少 60 小时。这意味着庆大霉素释放涂层有可能有助于改善无水泥全髋关节置换术中的感染预防。